Two COPD exacerbation occurred before any coil treatment and were included in the > 1 month coil treatment. b. One thoracic pain occurred before any coil treatment, and was included in the >30 days-12 months Coil. c. In the coil group: ≤ 30 days: cough (n=3), bronchospasm (n=1), dyspnea (n=1), bacteria on bronchial aspiration pre-coil treatment without respiratory symptoms (n=1); >30 days: dyspnea (n=1), pulmonary nodule (n=1). In the SOC group: cough (n=1), dyspnea (n=1).
eBox. Inclusion and Exclusion Criteria
Inclusion Criteria:
• Bilateral emphysema on Chest CT Scan • Post bronchodilator FEV 1 < 15% predicted
• Post-bronchodilator change in FEV 1 > 20%
• Severe recurrent respiratory infections requiring more than 2 hospitalization stays within the past twelve months
• COPD exacerbation requiring hospital stay within 3 months
• Pulmonary Hypertension (Pulmonary systolic pressure >50 mmHg on cardiac echo)
• Patient unable to perform a 6-min walking test in room air (no restriction on distance)
• Giant bulla of more than 1/3 of the lung field on Chest CT
• Strictly homogeneous emphysema on Chest CT (investigator interpreted)
• Clinically significant bronchiectasis
• Past history of lobectomy, lung volume reduction surgery, lung transplantation
• Any extrapulmonary diseases compromising survival or evaluation within the protocol (severe cardiac disease, severe renal insufficiency, cancer…)
• Lung carcinoma or pulmonary nodule on CT scan requiring Chest CT scan follow-up
• Contraindication to general anesthesia 
